Literature DB >> 1720495

An automated microassay for enzyme inhibitory effects of M2 antibodies in primary biliary cirrhosis.

K L Teoh1, M J Rowley, I R Mackay.   

Abstract

In primary biliary cirrhosis (PBC), autoantibodies are produced to the M2 group of mitochondrial antigens, of which a major constituent is the E2 subunit of the pyruvate dehydrogenase complex (PDC). These antibodies, in addition to conventional reactivities with PDC, characteristically inhibit the catalytic function of PDC in vitro, as judged by a macroinhibition assay based on spectrophotometry. We describe a microinhibition assay adapted for microtitre plates and for an automated readout of results by an ELISA plate reader. We show that this microassay has a sensitivity similar to that of the macroassay. In a study of 83 sera, from PBC and other diseases, the inhibitory microassay proved specific for PBC. This automated inhibitory microassay for PBC-sera could become a primary laboratory procedure for the diagnosis of PBC, particularly because it may identify antibodies to the actual autoepitope on the PDC-E2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720495     DOI: 10.1111/j.1600-0676.1991.tb00531.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

Review 1.  Enzyme inhibition assay for pyruvate dehydrogenase complex: clinical utility for the diagnosis of primary biliary cirrhosis.

Authors:  Katsuhisa Omagari; Hiroaki Hazama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

2.  Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis.

Authors:  H Hazama; K Omagari; J Masuda; H Kinoshita; K Ohba; K Sakimura; I Matsuo; H Isomoto; K Murase; I Murata; S Kohno
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.

Authors:  K Omagari; M J Rowley; J A Jois; S J Feeney; K Komatsu; T Maeda; S Onishi; K Yamazaki; K Suzuki; C Galperin; I R Mackay
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.